Details for New Drug Application (NDA): 202350
✉ Email this page to a colleague
The generic ingredient in MEMANTINE HYDROCHLORIDE is donepezil hydrochloride; memantine hydrochloride. There are thirty-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the donepezil hydrochloride; memantine hydrochloride profile page.
Summary for 202350
Tradename: | MEMANTINE HYDROCHLORIDE |
Applicant: | Strides Pharma |
Ingredient: | memantine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 202350
Mechanism of Action | NMDA Receptor Antagonists |
Medical Subject Heading (MeSH) Categories for 202350
Suppliers and Packaging for NDA: 202350
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MEMANTINE HYDROCHLORIDE | memantine hydrochloride | TABLET;ORAL | 202350 | ANDA | Strides Pharma Science Limited | 64380-745 | 64380-745-03 | 60 TABLET in 1 BOTTLE (64380-745-03) |
MEMANTINE HYDROCHLORIDE | memantine hydrochloride | TABLET;ORAL | 202350 | ANDA | Strides Pharma Science Limited | 64380-745 | 64380-745-30 | 10 BLISTER PACK in 1 CARTON (64380-745-30) / 10 TABLET in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | May 23, 2017 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | May 23, 2017 | TE: | AB | RLD: | No |
Complete Access Available with Subscription